INTRODUCTION
Abnormal uterine bleeding is a common problem amongst women and is associated with an array of symptoms. Frequent complaints include heavier or prolonged menstrual flow with or without pain, passage of clots, weakness, lethargy associated with social embarrassment, significant alteration in lifestyle of individual and sexual compromise. Accurate determination of the prevalence of abnormal uterine bleeding is difficult, however approximately 15% to 20% of scheduled office gynaecological visits are for abnormal uterine bleeding.
Women who experience abnormal uterine bleeding will often present to a physician because of a subsequent negative impact on their daily lives and activities. 2, 3 Abnormal uterine bleeding has been shown to adversely affect mood, energy/vitality, work productivity, social interactions, family life and sexual functioning. 4, 5 The effect abnormal uterine bleeding has on a women's Health Related Quality of Life (HRQL) derives from both the efforts associated with managing menstrual bleeding and the consequences of excessive blood loss, such as fatigue and iron deficiency anaemia. 6 Abnormality of menstruation is primarily a disorder of hypothalamico-pituitary-ovarian axis either through direct effect or indirectly by their effect on target organ. Endocrinological disturbances other than the reproductive hormones form a small but significant sub-group in the aetiopathogenesis of abnormal uterine bleeding. Amongst the endocrinological causes, after the pituitary, thyroid is probably the most important endocrine organ which exerts a broad range of effects on the development, growth, metabolism and function of virtually every organ system in the human body. 7 Alterations in production and activity of the thyroid hormones thyroxine (T 4 ) and tri-iodothyronine (T 3 ) may result in menstrual abnormality. Both hyperthyroidism and hypothyroidism may result in menstrual disturbances.
In hyperthyroidism, amenorrhoea was described as early as 1840 by Von Basedow. 8 The most common manifestation of hyperthyroidism is oligomenorrhoea and anovulation. It may also cause hypomenorrhoea or menorrhagia.
Hypothyroidism even in subclinical form may result in excessive menstrual bleeding and severe blood loss. The mechanism of menorrhagia in hypothyroidism is incompletely understood. It is postulated that infrequent or absent ovulation leads to deficient secretion of luteinizing hormone which may result in relative estrogen excess thereby causing menorrhagia. There may be episodes of ammenorhoea interspersed with periods of heavy vaginal bleeding also. Various studies have reported that there are changes in cycle length, amount and duration of bleeding associated with thyroid disorders. Sometimes they may also present with infertility, recurrent pregnancy losses and galactorrhoea Sub-clinical thyroid dysfunction may go unnoticed by unwary clinicians as these patients do not exhibit clinically overt physical symptoms and signs. This may lead to avoidable surgical interference and related complications. With the advent of modern techniques the estimation of various hormones in blood is 9 possible in rapid and reliable manner. The diagnosis of various endocrine disorders can be easily made and medical treatment can be properly instituted. The results are usually very gratifying as patient is virtually symptom free on adequate treatment.
It has been stated that menorrhagia is more common in hypothyroidism or myxoedema, whilst anovulation or oligomenorrhoea is common in hyperthyroidism. The relative frequency and type of menstrual disorders and the chronology of the onset of reproductive dysfunction with respect to the onset and type of thyroid disorder have not been well defined. It is common practice to investigate for thyroid functions when goiter or clinical symptoms and signs are present.
METHODS
The present study has been carried out at Obstetrics and Gynaecology outpatient department of MGM Medical College and Hospital; Kalamboli. The study consists of 100 patients coming to OPD with complaints of abnormal uterine bleeding from May 2011 to November 2013.
Sample size

patients
Ethical committee approval
Permission from ethical committee of MGM Hospital had been taken before starting the proposed study and informed consent from all the subjects recruited in the present study was obtained beforehand.
Inclusion criteria
All females in 19 to 45 years of age group were included as subjects in proposed study Clinical examination included general examination, systemic examination, routine gynaecological examination and examination of thyroid gland.
Patients with clinical signs and symptoms of thyroid disease were excluded.
All these patients were subjected to routine investigations like haemoglobin, blood counts, urine examination for albumin, sugar, microscopy, bleeding time, clotting time to rule out coagulation defect.
Then all patients were subjected to estimation of serum T 3 , T 4 , TSH.
T3 and T4 were estimated with Enzyme Linked ImmuneSorbant Assay (ELISA).
TSH was estimated by ultrasensitive fully automated ELISA assay.
Lab Life ER 2007 Microplate ELISA washer and reader is the instrument used for the present study.
These tests were done in random blood samples as the variation in TSH secretion due to circadian rhythm is small and does not influence the timing of blood sampling.
3 parameters were noted as 1. Serum T3 2. Serum T4 3. Serum TSH Considering their normal values; patients were categorized into four groups as follows:
1. Euthyroid 2. Subclinical hypothyroid 3. Hypothyroid 4. Hyperthyroid
RESULTS
Dysfunctional uterine bleeding is one of the most frequently encountered condition in gynaecological practice.
The following tables will analyse:
1. Age 2. Parity 3. Symptomatology of DUB 4. Association with thyroid dysfunction Total number of patients studied was 100. The above column shows relationship of DUB with parity. Among 100 cases of DUB, 19 patients were unmarried and nulliparas were 9. 10 patients were para 1. 11 patients were para 4. 9 patients were para 5. In this study maximum number of patients were para 2 (24%) and minimum number of patients presenting as clinical DUB were of para 5 and nulliparas. The above column shows 100 patients who came with the complaint of different bleeding pattern. Commonest was menorrhagia 40%. Among others 18% presented with acyclical, 15% with oligomenorrhoea, 18% had polymenorrhagia, 4% had polymenorrhoea, 2% had hypomenorrhoea, 3% had metrorrhagia. Maximum patients were seen with complaint of menorhhagia, following which polymenorrhagia and acyclical bleeding was seen (18% each). Patients with age less than or equal to 20 years, most common bleeding pattern was menorrhagia (45.4%).
Followed by acyclical bleeding (36.3%). Oligomenorhoea was present in 4.5% of the cases.
Similarly in age group 21-≤30 years and 31-≤40 years, the commonest bleeding pattern was menorrhagia.
Whereas in patients ≥41 years had polymenorrhageoa and menorrhagia are commonest bleeding pattern. According to this Table 5 , maximum number of apparently normal patients with DUB belonged to the category of subclinical hypothyroidism (18%). Hormonal levels revealing profound hypothyroidism in patients without any symptoms was present in only 9% of cases. 3% of cases had hyperthyroidism though they were clinically normal. This Table 6 shows the relationship between thyroid dysfunction to different age groups. Thyroid dysfunction was commonest in the age group of 41-45 years (42.8%). Followed with 31.8% in 31-40 and ≤20 years. Thyroid dysfunction was least common in the age group of 21-30 years (22.2%). This shows that thyroid dysfunction becomes more common as age advances and in this study it is commonly seen in age group of more than 41-45 years. Table 7 shows the relationship of hypothyroidism, subclinical hypothyroidism and hyperthyroidism to the different types of clinically diagnosed cases of DUB.
In acyclical metropathia, patients were hypothyroid in 11.1% of cases and 11.1% of patients had subclinical hypothyroidism. Whereas in patients with menorrhagia 20% of patients had hypothyroidism and 12.5% of patients had subclinical hypothyroidism. Patients with oligomenorrhoea had hyperthyroidism in 13.33% of patients, hypothyroidism in 60% of patients and subclinical hypothyroidism in 6.66%. In polymenorrhoea patients 83.3% of cases had profound hypothyroidism.
So patients who were subclinically hypothyroid were maximally presenting as polymenorrhoea (50%) and menorrhagia (12.5%) and only 6.66% of patients had oligomenorrhoea. Patients who were profound hypothyroid were predominantly having polymenorrhagia (83.33%) and (60%) of patients had oligomenorrhoea.
On the other hand patients who were hypothyroid also presented as oligomenorrhoea.
Subclinical hypothyroid patients have polymenorrhoea and menorrhagia as their commonest bleeding pattern. 
DISCUSSION
Menorrhagia is a frequent debilitating symptom in gynaecological practice resulting in need for repeated curettage and hysterectomy with its attendant morbidity and mortality. Objective measurements have shown that mean menstrual blood loss in each menstrual cycle is 35 ml and menstrual blood loss is considered to be excessive when it is more than 80 ml per cycle (90 th percentile).
The aetiology of menorrhagia is very diverse. It may be due to systemic conditions like hormonal imbalance (usually hypothyroidism and hyperthyroidism), or local lesions of genital tract like endometrial hyperplasia, pelvic inflammatory disease, endometriosis, benign tumours (leiomyoma, polyps) and malignant tumours (endometrial carcinoma). In more than half of the subjects the cause is usually not apparent.
Thyroid dysfunction is one of the common causes of excessive menstrual blood loss and menstrual irregularities. Menorrhagia has been reported in 32% of subjects with myxoedema 10 and in 32.4%. 11 It may also lead to anovulation, infertility and recurrent abortion. The onset of hypothyroidism is so insidious that classic clinical manifestation may take months and years to appear. 12 Furthermore menorrhagia may be the only presenting complain in hypothyroid women. 13 With the advent of modern hormonal assay techniques precise estimation of thyroid hormones in serum is possible in a rapid and reliable manner. Treatment of hypothyroidism is very satisfying as it usually relieves patient of all the symptoms. Hence in investigating a patient with menorrhagia and/or menstrual irregularities, evaluation of thyroid functional status forms an essential component. Early detection of hypothyroidism in such subjects saves the patient from recurrent curettage and at times hysterectomy.
Among the patients with abnormal thyroid function, significantly higher number of patients had hypothyroidism associated with menorrhagia as an abnormal menstrual pattern (P ≤0.001) as per chi square test, which is statistically highly significant. Similar findings were reported by various authors as given below:
Following Table 8 shows type of menstrual abnormality commonly seen in hypothyroidism as per various authors. 
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Authors
Menorrhagia Doifode et al. (2001) 63.3% Singh et al. (1990) 44.4% Wilansky and Bernard (1989) 100% Present study (2013) 32.5%
From this Table 8 , it is seen that incidence of menorrhagia is 40%-60% in cases of hypothyroidism in most of other studies. However, in the present study, the most probable reason for a lower incidence of menorrhagia in hypothyroidism is that patients with clinically apparent thyroid symptomatology were all excluded from beginning of study.
In the present study 100 cases were taken with the complaint of abnormal menstruation. Cases of acyclical metropathia, menorrhagia, In the author's study patients with clinical signs and symptoms of hypothyroidism were also included, whereas in the present study patients with clinically diagnosed DUB with signs and symptoms of hypothyroidism were excluded. 14 In the present study hypothyroidism was the commonest thyroid dysfunction seen in patient with all the seven different types of menstrual disturbances. In the following table the commonest menstrual disturbances in hypothyroidism is shown in the present study and in the author's study. The type of menstrual abnormality commonly seen in hypothyroidism was menorrhagia (63.33%) in author's study. Polymenorrhagia was the commonest menstrual abnormality in the present study (35.36%).
Polymenorrhagia was the next common menstrual abnormality 23.33% in the author's study. Author's study had excluded cases of polymenorrhoea. However, in the present study menorrhagia and oligomenorrhoea were together common menstrual abnormality in 27.04% and 20.8% of hypothyroid cases.
In the present study, hyperthyroidism was seen only in cases of oligomenorrhoea (66.6%) and polymenorrhagia (33.3%).
Reversely, oligomenorrhoea was most commonly observed in patients suffering of hypothyroidism (60%) and subsequently euthyroidism (20%) and very less in hyperthyroidism (13.33%). This Table 12 compares the relationship between age pattern with thyroid dysfunction among patients with DUB in the present study and in author's study. From this table it is noted that thyroid dysfunction is commonest in the age group of more than 40 years, both in the present study as well as in the author's study.
Thus, the present study was aimed at detecting and evaluating thyroid dysfunction in patients with provisional diagnosis of DUB and positive cases were referred to physician for further management.
Our study concludes that thyroid disorder should be considered as an important aetiological factor for menstrual abnormality.
Thus biochemical evaluation T 3 , T 4 and TSH estimations should be made mandatory in DUB cases to detect profound and subclinical thyroid dysfunction.
These patients with thyroid dysfunction, if given medical treatment, it is possible to avoid unnecessary hormonal treatment and costly surgical interventions.
